Utique Enterprises Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Utique Enterprises Ltd is ₹ 3.89 as of 25 Aug 16:01 . The P/E Ratio of Utique Enterprises Ltd is 4.2 as of March 2021 .The P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd is 0 as of March 2021 . The Market Cap of Utique Enterprises Ltd is ₹ 10.19 crore as of March 2021 .The Market Cap of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2021 . The revenue of Utique Enterprises Ltd for the Jun '26 is ₹ 8.55 crore as compare to the Mar '26 revenue of ₹ -2.42 crore. This represent the decline of -453% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Utique Enterprises Ltd for the Jun '26 is ₹ 2.81 crore as compare to the Mar '26 ebitda of ₹ -2.87 crore. This represent the decline of -197% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Utique Enterprises Ltd changed from ₹ 0.11 crore to ₹ 2.32 crore over 9 quarters. This represents a CAGR of 287.69% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Utique Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Utique Enterprises Ltd

Unique Enterprises Limited was initially incorporated as 'Apple Finance Limited' in October, 1985.
Promoted by Atul Nishar, the Company was engaged into Computer Education and Financial Services.
Effective February 4, 2020, the name of the Company was changed from Apple Finance Limited to Utique Enterprises Limited.
The Company is presently engaged in general trading of precious metal and trading in derivatives on recognized exchanges. The Company had a wholly-owned subsidiary, Apple Asset Management Limited (AAML).
The said subsidiary was in the business of managing Schemes of Apple Mutual Fund, viz.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Utique Enterprises Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Utique Enterprises Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Utique Enterprises Ltd is 19 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Utique Enterprises Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Utique Enterprises Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Utique Enterprises Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 31, 2026, the Utique Enterprises Ltd stock price is INR ₹3.57. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Utique Enterprises Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Utique Enterprises Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.